bf/NASDAQ:ANIP_icon.jpeg

COM:ANIPHARMACEUTICALS

ANI Pharmaceuticals

  • Stock

Last Close

55.86

22/11 21:00

Market Cap

1.19B

Beta: -

Volume Today

127.69K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
301K
-
28.75M
9,450.50%
15.38M
46.52%
3.93M
74.41%
-1.08M
127.35%
15.49M
1,539.96%
6.09M
60.67%
-22.55M
470.00%
-42.60M
88.94%
-47.90M
12.42%
18.78M
139.21%
depreciation and amortization
1.11M
-
3.88M
249.37%
6.90M
77.93%
22.34M
223.81%
27.93M
25.00%
33.74M
20.82%
44.61M
32.22%
44.64M
0.06%
47.25M
5.86%
59.65M
26.24%
59.79M
0.23%
deferred income tax
-195K
-
-14.46M
7,314.87%
-1.88M
87.02%
-8.91M
374.75%
3.56M
139.95%
-5.18M
245.51%
-9.13M
76.33%
-13.21M
44.57%
-16.75M
26.88%
-15.25M
8.96%
-11.74M
23.03%
stock based compensation
4.45M
-
3.42M
23.15%
3.86M
12.65%
6.07M
57.34%
6.09M
0.38%
6.78M
11.36%
9.22M
35.90%
12.94M
40.35%
10.49M
18.92%
14.60M
39.18%
20.65M
41.46%
change in working capital
-11.37M
-
-115K
98.99%
-13.86M
11,953.04%
-9.93M
28.38%
-5.65M
43.06%
5.97M
205.59%
-14.58M
344.32%
-12.63M
13.39%
-84K
99.33%
-51.30M
60,971.43%
24.86M
148.46%
accounts receivables
-7.08M
-
-4.78M
32.44%
-4.63M
3.11%
-23.96M
417.00%
-12.89M
46.20%
-4.74M
63.21%
-7.29M
53.64%
-23.66M
224.74%
-5.55M
76.56%
-36.91M
565.32%
3.36M
109.10%
inventory
-708K
-
-3.47M
389.83%
-5.87M
69.23%
-1.94M
66.98%
5.36M
376.37%
-379K
107.08%
-7.66M
1,921.11%
-2.76M
63.98%
3.22M
216.85%
-23.63M
832.82%
-5.84M
75.28%
accounts payables
-565K
-
225K
139.82%
-1.03M
556.44%
1.08M
204.77%
3K
99.72%
3.47M
115,433.33%
5.04M
45.38%
-2.29M
145.52%
10.17M
543.16%
5.04M
50.44%
7.55M
49.90%
other working capital
-3.02M
-
7.91M
362.25%
-2.33M
129.45%
14.90M
739.40%
1.88M
87.37%
7.62M
305.10%
-4.67M
161.29%
16.09M
444.30%
-7.93M
149.26%
4.20M
152.99%
19.79M
371.19%
other non cash items
217K
-
559K
157.60%
6.87M
1,129.16%
13.97M
103.26%
8.57M
38.64%
10.27M
19.83%
9.42M
8.23%
6.07M
35.54%
5.02M
17.32%
8.99M
79.09%
6.62M
26.43%
net cash provided by operating activities
-5.48M
-
22.03M
501.77%
17.26M
21.64%
27.47M
59.13%
39.42M
43.49%
67.07M
70.16%
45.63M
31.97%
15.27M
66.54%
3.32M
78.24%
-31.20M
1,039.28%
118.96M
481.24%
investments in property plant and equipment
-191K
-
-35.75M
18,619.37%
-32.68M
8.59%
-149.06M
356.08%
-107.99M
27.55%
-10.91M
89.90%
-27.55M
152.47%
-68.32M
148.00%
-23.64M
65.40%
-16.45M
30.39%
-18.51M
12.49%
acquisitions net
18.20M
-
-16.47M
-
-84.49M
-
-33K
99.96%
purchases of investments
sales maturities of investments
other investing activites
2.26M
-
-5.00M
-
2.65M
-
750K
71.69%
net cash used for investing activites
20.27M
-
-35.75M
276.41%
-32.68M
8.59%
-154.06M
371.38%
-107.99M
29.90%
-27.38M
74.65%
-27.55M
0.62%
-68.32M
148.00%
-105.48M
54.39%
-15.74M
85.08%
-18.51M
17.62%
debt repayment
-4.07M
-
-28.94M
-
-121.46M
319.71%
-15.53M
87.21%
-211.01M
1,258.38%
-3M
98.58%
-3M
0%
common stock issued
46.68M
-
5.74M
-
618K
89.23%
75M
12,035.92%
1.46M
98.06%
89.55M
6,042.04%
common stock repurchased
-433K
-
-113K
-
-122K
7.96%
-259K
112.30%
-659K
154.44%
-1.03M
56.45%
-1.52M
47.72%
-890K
41.56%
-1.96M
120.11%
-4.99M
154.57%
dividends paid
-5.74M
-
-618K
89.23%
-190K
69.26%
-1.63M
755.26%
-1.63M
0%
other financing activites
809K
-
124.97M
15,347.84%
1.18M
99.06%
-607K
151.48%
72.62M
12,063.10%
1.78M
97.55%
123.74M
6,847.67%
15.62M
87.38%
331.69M
2,023.74%
-12.50M
-
net cash used provided by financing activities
-3.69M
-
171.65M
4,753.10%
1.07M
99.38%
-729K
168.39%
72.36M
10,025.51%
-27.82M
138.44%
1.25M
104.49%
-1.44M
215.12%
194.59M
13,622.93%
-5.13M
102.63%
67.44M
1,415.63%
effect of forex changes on cash
net change in cash
11.09M
-
157.93M
1,323.58%
-14.35M
109.09%
-127.32M
787.05%
3.78M
102.97%
11.88M
214.01%
19.33M
62.74%
-54.49M
381.88%
92.43M
269.62%
-52.07M
156.33%
167.89M
422.44%
cash at beginning of period
11K
-
11.11M
100,854.55%
169.04M
1,422.17%
154.68M
8.49%
32.37M
79.08%
36.15M
11.69%
48.03M
32.86%
67.36M
40.25%
12.87M
80.90%
105.30M
718.38%
53.23M
49.45%
cash at end of period
11.11M
-
169.04M
1,422.17%
154.68M
8.49%
27.36M
82.31%
36.15M
32.10%
48.03M
32.86%
67.36M
40.25%
12.87M
80.90%
105.30M
718.38%
53.23M
49.45%
221.12M
315.38%
operating cash flow
-5.48M
-
22.03M
501.77%
17.26M
21.64%
27.47M
59.13%
39.42M
43.49%
67.07M
70.16%
45.63M
31.97%
15.27M
66.54%
3.32M
78.24%
-31.20M
1,039.28%
118.96M
481.24%
capital expenditure
-191K
-
-35.75M
18,619.37%
-32.68M
8.59%
-149.06M
356.08%
-107.99M
27.55%
-10.91M
89.90%
-27.55M
152.47%
-68.32M
148.00%
-23.64M
65.40%
-16.45M
30.39%
-18.51M
12.49%
free cash flow
-5.67M
-
-13.72M
141.78%
-15.42M
12.38%
-121.59M
688.56%
-68.57M
43.60%
56.16M
181.90%
18.08M
67.80%
-53.05M
393.41%
-20.32M
61.71%
-47.66M
134.58%
100.45M
310.77%

All numbers in (except ratios and percentages)